Hottest Stocks
(Over $10)
Hottest Stocks
($2-$10)
Biggest Losers
(Over $10)
Biggest Losers
($2-$10)
Hottest
Industries
Hottest
Sectors
EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for Meat-Tech 3D Ltd. (MTTCF : OTC)
 
 • Company Description   
D. Medical Industries Ltd. is a medical device company engaged through its subsidiaries in the research, development, manufacture and sale of products for diabetes treatment and drug delivery. Through its subsidiary NextGen Biomed Ltd., it also invests in select medical device opportunities. The Company's products include ADI Insulin pump and Lighty DD infusion set. ADI is an insulin delivery system, utilizing spring technology. A spring compressed when insulin is loaded creates internal pressure that controls the flow of a measured amount of insulin through the system. The Lighty DD infusion set is a novel infusion set designed to quickly identify situations in which the cannula of the infusion set is separated from the body. Lighty DD uses blocking mechanism that is integrated into the base of the infusion set. If the base is detached from the body, insulin flow is stopped and a pump alarm is sounded. D. Medical is also developing a continuous glucose monitor. The Company is based in Tirat Carmel, Israel.

Number of Employees:

 
 • Price / Volume Information   
Yesterday's Closing Price: $ Daily Weekly Monthly
20 Day Moving Average: shares
Shares Outstanding: (millions)
Market Capitalization: $ (millions)
Beta:
52 Week High: $1.00
52 Week Low: $0.25
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week % %
12 Week % %
Year To Date % %
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
3 HASADNA ST.
-
TIRAT CARMEL,L3 39026
ISR
ph: 972-73-250-7100
fax: 972-4850-0297
ir@dmedicalindustries.com http://www.dmedicalindustries.com
 
 • General Corporate Information   
Officers
Efraim Argaman - Chief Executive Officer
Amir Loberman - Chief Financial Officer
Hezkiah Tsoory - Chief Operating Officer
Zoe H. Myres - Chief Commercial Officer
Eyal Sheratzky - Director

Peer Information
- (-)
- (-)
- (-)
- (-)
- (-)
- (-)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: MED INSTRUMENTS
Sector: Medical
CUSIP: M6S89X179
SIC: 3841
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: -
Next Expected EPS Date: -
Share - Related Items
Shares Outstanding:
Most Recent Split Date: 11.00 (0.10:1)
Beta:
Market Capitalization: $ (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: %
Current Fiscal Quarter EPS Consensus Estimate: $ Indicated Annual Dividend: $0.00
Current Fiscal Year EPS Consensus Estimate: $ Payout Ratio:
Number of Estimates in the Fiscal Year Consensus: Change In Payout Ratio:
Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00
Next EPS Report Date: -  
 

 • Fundamental Ratios
P/E
Current FY Estimate: -
Trailing 12 Months: -
PEG Ratio: -
Price Ratios
Price/Book: -
Price/Cash Flow: -
Price / Sales: -
EPS Growth
vs. Year Ago Period: -%
vs. Previous Quarter: -%
Sales Growth
vs. Year Ago Period: -%
vs. Previous Quarter: -%
ROE
03/31/22 - -
12/31/21 - -
09/30/21 - -
ROA
03/31/22 - -
12/31/21 - -
09/30/21 - -
Current Ratio
03/31/22 - -
12/31/21 - -
09/30/21 - -
Quick Ratio
03/31/22 - -
12/31/21 - -
09/30/21 - -
Operating Margin
03/31/22 - -
12/31/21 - -
09/30/21 - -
Net Margin
03/31/22 - -
12/31/21 - -
09/30/21 - -
Pre-Tax Margin
03/31/22 - -
12/31/21 - -
09/30/21 - -
Book Value
03/31/22 - -
12/31/21 - -
09/30/21 - -
Inventory Turnover
03/31/22 - -
12/31/21 - -
09/30/21 - -
Debt-to-Equity
03/31/22 - -
12/31/21 - -
09/30/21 - -
Debt-to-Capital
03/31/22 - -
12/31/21 - -
09/30/21 - -
 

Powered by Zacks Investment Research ©